Know what a violation
actually costs you
Plug in the violation type, your revenue, and the affected count. See the maximum penalty exposure under PIPEDA, Law 25, and CASL β calibrated to recent OPC / CAI / CRTC enforcement actions. Drives executive urgency in 30 seconds.
Every framework. One view.
See PIPEDA, Law 25, CASL, FINTRAC, and PHIPA compliance in a single dashboard. Color-coded heatmaps show you exactly where risk lives across your organization β no spreadsheets, no manual chasing.
Request a demoFrom point-in-time to real-time.
Traditional compliance is a snapshot. Valdra continuously monitors your posture as your business changes β new vendors, new data flows, new regulations. You see problems before your regulator does.
Request a demoAdditional features
Request a demoPIPEDA Penalty Calculator
Up to $100K per violation under current PIPEDA + future Bill C-27 fines (up to 5% of global revenue or $25M).
Law 25 Penalty Calculator
Up to $25M CAD or 4% of worldwide revenue under Quebec Law 25 β the harshest privacy law in North America.
CASL Penalty Calculator
Up to $10M CAD per violation under CRTC enforcement. Includes director and officer personal liability scenarios.
Multi-Violation Scenarios
Model compound penalties when a single incident triggers PIPEDA + Law 25 + CASL simultaneously β common in breach scenarios.
Recent Enforcement Citations
Every calculation links to recent OPC findings, CAI rulings, or CRTC compliance actions of similar scale β defensible numbers.
Board-Pack Export
Generate a one-page exposure summary suitable for board, audit committee, or investor decks.
βBefore Valdra, our compliance posture lived in a spreadsheet nobody could read. Now our board gets a live dashboard and we can demonstrate continuous improvement to the OPC.
MTMarie TremblayChief Privacy Officer Β· Northern Benefits Co.
Learn more about Valdra
Get compliant and build trust
Join hundreds of Canadian organizations using Valdra to automate their privacy obligations β no consultants required.
π Canadian data residency Β· PIPEDA compliant Β· SOC 2 in progress